Xeris Biopharma Holdings, Inc.

XERS

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001867096

SEC filings (opens in a new tab)

In the last 90 days, Xeris Biopharma Holdings, Inc. insiders filed 0 open-market purchases and 11 sales; 242 institutions reported holding it in 13F filings for Q2 2026, worth $857.1M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Xeris Biopharma Holdings, Inc. changed between Q2 2024 and Q3 2024.

All holders in Q3 2024 All holders in Q2 2024

13F holders of XERS: Q2 2024 compared with Q3 2024
Measure	Q2 2024	Of which not filed for Q3 2024	Q3 2024	Change
Holders	135	2	144	+11
Shares	60.7M	10.3M	63.9M	+13.5M (+26.9%)
Value	$136.6M	$23.3M	$182.2M	+$68.9M (+60.8%)

2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to XERS in Q3 2024
Institution	Shares	Value	% of portfolio
BlackRock, Inc.	10,734,031	$30.6M	0.00%
AIGH Capital Management LLC	2,185,654	$6.23M	2.92%
Walleye Capital LLC	1,121,738	$3.20M	0.03%
Kennedy Capital Management, Inc.	604,857	$1.72M	0.04%
ExodusPoint Capital Management, LP	84,740	$242.0K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	83,108	$236.9K	0.00%
Intech Investment Management LLC	45,608	$130.0K	0.00%
Raymond James & Associates	42,062	$119.9K	0.00%
Occudo Quantitative Strategies LP	32,785	$93.4K	0.02%
Prudential Financial Inc	29,945	$85.3K	0.00%
Mackenzie Financial Corp	23,799	$67.8K	0.00%
Savant Capital, LLC	22,115	$63.0K	0.00%
Squarepoint Ops LLC	18,685	$53.3K	0.00%
Quantbot Technologies LP	15,425	$44.0K	0.00%
Cerity Partners LLC	15,196	$43.3K	0.00%
Wealth Enhancement Advisory Services, LLC	12,421	$35.4K	0.00%
Picton Mahoney Asset Management	1,015	$3.00K	0.00%
True Wealth Design, LLC	916	$2.61K	0.00%
Spectrum Wealth Counsel, LLC	834	$2.38K	0.00%
Comerica Bank	611	$1.74K	0.00%
Federated Hermes, Inc.	181	$516	0.00%
Sterling Capital Management LLC	142	$405	0.00%
American Capital Advisory, LLC	50	$143	0.00%
Bryn Mawr Trust Co	40	$114	0.00%
Danske Bank A/S	2	$6	0.00%

Sold out (14)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of XERS in Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
MPM Oncology Impact Management LP	4,830,526	$10.9M
Invenomic Capital Management LP	592,078	$1.33M
Cetera Investment Advisers	118,443	$266.5K
Soleus Capital Management, L.P.	62,083	$139.7K
Dimensional Fund Advisors LP	48,663	$109.5K
Quarry LP	30,000	$67.5K
Two Sigma Investments, LP	26,803	$60.3K
Sanctuary Advisors, LLC	33,429	$58.5K
Two Sigma Advisers, LP	23,559	$53.0K
Two Sigma Securities, LLC	12,900	$29.0K
Simplicity Wealth,LLC	12,156	$27.4K
TownSquare Capital, LLC	11,267	$25.4K
National Bank of Canada	1,890	$4.10K
ADAR1 Capital Management, LLC	1,000	$2.25K

Not filed for Q3 2024 yet (2)

Institutions that held Xeris Biopharma Holdings, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding XERS in Q2 2024 that haven't filed for Q3 2024
Institution	Shares, Q2 2024	Value, Q2 2024
BlackRock Inc.	10,332,078	$23.2M
Benjamin F. Edwards & Company, Inc.	3,000	$7.00K